Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
Public ClinicalTrials.gov record NCT06940154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Participants With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation
Study identification
- NCT ID
- NCT06940154
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 159 participants
Conditions and interventions
Conditions
Interventions
- Rademikibart in prefilled syringe Combination Product
- Matching placebo in prefilled syringe Drug
Combination Product · Drug
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 12, 2025 (Actual)
- Primary completion
- Jul 30, 2026 (Actual)
- Completion
- Aug 26, 2026 (Actual)
- Last update posted
- Sep 16, 2026
2025 – 2026
United States locations
- U.S. sites
- 21
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Lung Health Center | Birmingham | Alabama | 35233 | — |
| Leland Stanford Junior University, Stanford Hospital | Palo Alto | California | 94304 | — |
| Amicis Research Center | Valencia | California | 91355 | — |
| National Jewish Health | Denver | Colorado | 80206 | — |
| Columbus Clinical Services, LLC | Miami | Florida | 33125 | — |
| Pharmax Research of South Florida, Inc. | Miami | Florida | 33175 | — |
| Health Synergy Clinical Research, LLC | West Palm Beach | Florida | 33407 | — |
| Primeway Clinical Research Group | Fayetteville | Georgia | 30214 | — |
| Pivotal Research Solutions | Stonecrest | Georgia | 30038 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Ochsner Medical Complex - The Grove | Baton Rouge | Louisiana | 70836 | — |
| Stony Brook University Hospital | Stony Brook | New York | 11733 | — |
| Duke Asthma, Allergy, and Airway Center | Durham | North Carolina | 27705 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Clinical Research of Rock Hill | Rock Hill | South Carolina | 29732 | — |
| Inquest Clinical Research | Baytown | Texas | 77521 | — |
| Premier Pulmonary Critical Care and Sleep Medicine | Denison | Texas | 75020 | — |
| DCT- McAllen Primary Care Research, LLC dba Discovery Clinical Trials | McAllen | Texas | 78503 | — |
| Vermont Lung Center | Colchester | Vermont | 05446 | — |
| Carilion Medical Center / Carilion Roanoke Memorial Hospital | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06940154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06940154 live on ClinicalTrials.gov.